Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma

BACKGROUND & AIM: In clinical practice, transarterial chemoembolization (TACE) has been widely used for the treatment of hepatocellular carcinoma (HCC) beyond as well as within guideline recommendations. Here we aimed to verify whether two consecutive non-responses could be an optimal criterion...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Choi, Jonggi, Lee, Danbi, Shim, Ju Hyun, Kim, Kang Mo, Lim, Young-Suk, Lee, Yung Sang, Lee, Han Chu
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2020
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7055892/
https://ncbi.nlm.nih.gov/pubmed/32130270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0229696
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki